209 related articles for article (PubMed ID: 34378812)
21. Efficacy and safety of radiofrequency in the treatment of hidradenitis suppurativa; a systematic review.
Nilforoushzadeh MA; Heidari N; Heidari A; Ghane Y; Hosseini S; Lotfi Z; Jaffary F; Nobari MN; Aghamiri ZS; Nobari NN
Lasers Med Sci; 2024 May; 39(1):139. PubMed ID: 38795173
[TBL] [Abstract][Full Text] [Related]
22. Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review.
Snyder CL; Gibson RS; Chen SX; Porter ML; Kimball AB
Int J Womens Dermatol; 2024 Jun; 10(2):e152. PubMed ID: 38854891
[TBL] [Abstract][Full Text] [Related]
23. International Hidradenitis Suppurativa Severity Scoring System (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging: A post hoc analysis of the SUNRISE and SUNSHINE phase 3 trials of secukinumab.
Zouboulis CC; Prens EP; Sayed CJ; Molina-Leyva A; Bettoli V; Romanelli M; Szepietowski JC; Martinez AL; Kasparek T; Lobach I; Wozniak MB; Ortmann CE; Thomas N; Bachhuber T; Ravichandran S; Tzellos T
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e496-e499. PubMed ID: 38058224
[No Abstract] [Full Text] [Related]
24. Clinical Features and Response to Treatment in Elderly Subjects Affected by Hidradenitis Suppurativa: A Cohort Study.
Antonelli F; Ippoliti E; Rosi E; Moltrasio C; Malvaso D; Botti E; Abeni D; Dini V; Cannizzaro MV; Bruni M; Di Nardo L; Fargnoli MC; Romanelli M; Fania L; Bianchi L; Marzano AV; Prignano F; Peris K; Chiricozzi A
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137823
[TBL] [Abstract][Full Text] [Related]
25. Demographic Gaps and Requirements for Participation: A Systematic Review of Clinical Trial Designs in Hidradenitis Suppurativa.
James JF; Madray VM; Salame N; Hasan SB; White MS; Barron JR; Kirby J; Ingram JR; Orenstein LAV
Dermatology; 2023; 239(1):45-51. PubMed ID: 36108592
[TBL] [Abstract][Full Text] [Related]
26. Weekly adalimumab treatment decreased disease flare in hidradenitis suppurativa over 36 weeks: integrated results from the phase 3 PIONEER trials.
van der Zee HH; Longcore M; Geng Z; Garg A
J Eur Acad Dermatol Venereol; 2020 May; 34(5):1050-1056. PubMed ID: 31630445
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of Subantimicrobial, Modified-Release Doxycycline Compared to Regular-Release Doxycycline for the Treatment of Hidradenitis Suppurativa.
Kontochristopoulos G; Tsiogka A; Agiasofitou E; Kapsiocha A; Soulaidopoulos S; Liakou AI; Gregoriou S; Rigopoulos D
Skin Appendage Disord; 2022 Nov; 8(6):476-481. PubMed ID: 36407641
[TBL] [Abstract][Full Text] [Related]
28. Biologics and Small Molecule Inhibitors for Treating Hidradenitis Suppurativa: A Systematic Review and Meta-Analysis.
Huang CH; Huang IH; Tai CC; Chi CC
Biomedicines; 2022 Jun; 10(6):. PubMed ID: 35740325
[TBL] [Abstract][Full Text] [Related]
29. Ultrasound-assisted intralesional corticosteroid infiltrations for patients with hidradenitis suppurativa.
Salvador-Rodríguez L; Arias-Santiago S; Molina-Leyva A
Sci Rep; 2020 Aug; 10(1):13363. PubMed ID: 32770058
[TBL] [Abstract][Full Text] [Related]
30. Factors Affecting Treatment Selection Among Patients With Hidradenitis Suppurativa.
Salame N; Sow YN; Siira MR; Garg A; Chen SC; Patzer RE; Kavalieratos D; Orenstein LAV
JAMA Dermatol; 2024 Feb; 160(2):179-186. PubMed ID: 38198173
[TBL] [Abstract][Full Text] [Related]
31. Update on Ultrasound Diagnostic Criteria and New Ultrasound Severity and Activity Scorings of Hidradenitis Suppurativa: Modified SOS-HS and US-HSA.
Wortsman X
J Ultrasound Med; 2024 Jan; 43(1):207-213. PubMed ID: 37846584
[TBL] [Abstract][Full Text] [Related]
32. Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape.
Krueger JG; Frew J; Jemec GBE; Kimball AB; Kirby B; Bechara FG; Navrazhina K; Prens E; Reich K; Cullen E; Wolk K
Br J Dermatol; 2024 Jan; 190(2):149-162. PubMed ID: 37715694
[TBL] [Abstract][Full Text] [Related]
33. Resorcinol 10% as a Promising Therapeutic Option for Mild Hidradenitis Suppurativa: A Prospective, Randomized, Open Study.
Katoulis A; Efthymiou O; Liakou A; Pappa G; Kanelleas A; Koumaki D; Bozi E; Sgouros D
Skin Appendage Disord; 2023 Dec; 9(6):438-443. PubMed ID: 38058541
[TBL] [Abstract][Full Text] [Related]
34. Biologics for Hidradenitis suppurativa: evolution of the treatment paradigm.
Maronese CA; Moltrasio C; Genovese G; Marzano AV
Expert Rev Clin Immunol; 2024 May; 20(5):525-545. PubMed ID: 38130204
[TBL] [Abstract][Full Text] [Related]
35. A Review of the Current Landscape of Hidradenitis Suppurativa Treatment Development.
Westerkam L; Sayed C
J Drugs Dermatol; 2023 Oct; 22(10):1021-1026. PubMed ID: 37801538
[TBL] [Abstract][Full Text] [Related]
36. Response to adalimumab in Caucasian and Asian patients with hidradenitis suppurativa: A retrospective cohort study of an Australian cohort stratified by patient-reported ethnicity.
Pham J; Flora A; Guttman L; Allan T; Chandran NS; Frew JW
Australas J Dermatol; 2024 Jun; ():. PubMed ID: 38924541
[TBL] [Abstract][Full Text] [Related]
37. Dapsone to Treat Moderate-to-Severe Hidradenitis Suppurativa: A Retrospective Case-Series.
Baroudi B; Bashyam AM; Feldman SR; Pichardo RO
J Drugs Dermatol; 2023 Nov; 22(11):e12-e16. PubMed ID: 37943259
[TBL] [Abstract][Full Text] [Related]
38. Real-world effectiveness and safety of the LAight-therapy in patients with hidradenitis suppurativa.
Strobel A; Schultheis M; Staubach P; Grabbe S; Mann C; Hennig K; Szepietowski JC; Matusiak L; Krajewski P; von Stebut E; Garcovich S; Bayer H; Heise M; Podda M; Kirschner U; Nikolakis G
J Dtsch Dermatol Ges; 2024 May; ():. PubMed ID: 38807028
[TBL] [Abstract][Full Text] [Related]
39. Automated classification of hidradenitis suppurativa disease severity by convolutional neural network analyses using calibrated clinical images.
Wiala A; Ranjan R; Schnidar H; Rappersberger K; Posch C
J Eur Acad Dermatol Venereol; 2024 Mar; 38(3):576-582. PubMed ID: 38013510
[TBL] [Abstract][Full Text] [Related]
40. Doppler ultrasound protocol for patients with hidradenitis suppurativa.
Denofre ATAS; Stecca CM; Serrano JYM; Buffo TH; Dertkigil RP; Magalhães RF
An Bras Dermatol; 2024 Jun; ():. PubMed ID: 38851892
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
